Description
ATLANTA PHARMACEUTICAL REVERSE DISTRIBUTION INCREASE
Base award description: ATLANTA PHARMACEUTICAL REVERSE DISTRIBUTION
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2019-02-08+$58,000= $58,000
- Mod P000012020-03-19-$8,222= $49,778
- Mod P000022020-06-01+$1,455= $51,233
- Mod P000032021-03-29+$11,000= $62,233
- Mod P000042021-06-01+$3,323= $65,555
- Mod P000052022-01-19+$645= $66,200
- Mod P000062022-04-28+$0= $66,200
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2019-02-08 | +$58,000 | $58,000 | ATLANTA PHARMACEUTICAL REVERSE DISTRIBUTION |
| Mod P00001· OTHER ADMINISTRATIVE ACTION | 2020-03-19 | −$8,222 | $49,778 | ATLANTA PHARMACEUTICAL REVERSE DISTRIBUTION |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-06-01 | +$1,455 | $51,233 | ATLANTA PHARMACEUTICAL REVERSE DISTRIBUTION |
| Mod P00003· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-03-29 | +$11,000 | $62,233 | ATLANTA PHARMACEUTICAL REVERSE DISTRIBUTION |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-06-01 | +$3,323 | $65,555 | ATLANTA PHARMACEUTICAL REVERSE DISTRIBUTION INCREASE |
| Mod P00005· OTHER ADMINISTRATIVE ACTION | 2022-01-19 | +$645 | $66,200 | ATLANTA PHARMACEUTICAL REVERSE DISTRIBUTION INCREASE |
| Mod P00006· OTHER ADMINISTRATIVE ACTION | 2022-04-28 | +$0 | $66,200 | ATLANTA PHARMACEUTICAL REVERSE DISTRIBUTION INCREASE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI D4VCRL38H9C9)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026N0056 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · R706 · SUPPORT- MANAGEMENT: LOGISTICS SUPPORT | $19,978 | FY2026 |
| 36C25025P0850 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · Q517 · PHARMACY SERVICES | $7,485 | FY2025 |
| 36C25625P0370 | 256-NETWORK CONTRACT OFFICE 16 (36C256) · Q517 · PHARMACY SERVICES | $3,996 | FY2025 |
| 36C26025D0008 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · R706 · SUPPORT- MANAGEMENT: LOGISTICS SUPPORT | $0 | FY2025 |
| 36C26025N0080 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · R706 · SUPPORT- MANAGEMENT: LOGISTICS SUPPORT | $11,988 | FY2025 |
| 36C24824P0166 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · Q702 · TECHNICAL MEDICAL SUPPORT | $158,346 | FY2024 |
Other recipients under Q517 from 247-NETWORK CONTRACT OFFICE 7 (36C247) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24726P0615 | PHARMALINK INC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $20,400 | FY2026 |
| 36C24726P0429 | CARDINAL HEALTH 414, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $24,000 | FY2026 |
| 36C24726F0046 | MINBURN TECHNOLOGY GROUP, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $147,618 | FY2026 |
| 36C24726F0260 | NOVARTIS PHARMACEUTICALS CORPORATION | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $0 | FY2026 |
| 36C24725P0955 | ICP HOLDINGS, LLC | 247-NETWORK CONTRACT OFFICE 7 (36C247) | $38,000 | FY2025 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24719F0276_3600_36W79718D0002_3600 · retrieved 2026-09-26.